Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan

Mahmoodullah Azimi,1 Wazhma Masoom Dehzad,1 Mohammad Asif Atiq,1 Barin Bahain,1 Abdullah Asady2 1Department of Clinical Pharmacology, Kabul University of Medical Sciences, Kabul, Afghanistan; 2Department of Microbiology, Kabul University of Medical Sciences, Kabul, AfghanistanCorrespondence: Abdulla...

Full description

Bibliographic Details
Main Authors: Azimi M, Dehzad WM, Atiq MA, Bahain B, Asady A
Format: Article
Language:English
Published: Dove Medical Press 2021-10-01
Series:Infection and Drug Resistance
Subjects:
Online Access:https://www.dovepress.com/adverse-effects-of-the-covid-19-vaccine-reported-by-lecturers-and-staf-peer-reviewed-fulltext-article-IDR
_version_ 1818407316599341056
author Azimi M
Dehzad WM
Atiq MA
Bahain B
Asady A
author_facet Azimi M
Dehzad WM
Atiq MA
Bahain B
Asady A
author_sort Azimi M
collection DOAJ
description Mahmoodullah Azimi,1 Wazhma Masoom Dehzad,1 Mohammad Asif Atiq,1 Barin Bahain,1 Abdullah Asady2 1Department of Clinical Pharmacology, Kabul University of Medical Sciences, Kabul, Afghanistan; 2Department of Microbiology, Kabul University of Medical Sciences, Kabul, AfghanistanCorrespondence: Abdullah AsadyDepartment of Microbiology, Kabul University of Medical Sciences, Kabul, AfghanistanTel +93731087928Email asady_abdullah@yahoo.comPurpose: To evaluate the occurrence, extent, and severity of adverse reactions associated with the vaccine of COVID-19 (ChAdOx1 nCoV-19 vaccine or AstraZeneca) among Kabul University of Medical Sciences staff.Patients and Methods: A retrospective observational, interview-based study was conducted from 4 to 20 April, 2021, to evaluate the adverse reactions associated with the vaccine of COVID-19 (ChAdOx1 nCoV-19 vaccine or AstraZeneca) among the staff and lecturers of the Kabul University of Medical Sciences, Kabul, Afghanistan. Participants were interviewed following the administration of the first dose of the AstraZeneca vaccines. They were asked to report any adverse reactions that occurred within 8– 10 days after vaccination. The frequency, duration, severity, and outcome of the reactions were recorded. Association of the adverse reactions was analysed with the ages of participants and previous infection with SARS CoV-2.Results: The most common adverse reactions reported by the participants were muscle pain (68.3%), local pain (58.8%) at the site of injection (68.3%), fever (66.3%) and fatigue (66.3%). Almost half of the respondents reported chills, joint pain and headache after receiving the first shot of the vaccine. The frequency of adverse reactions was higher in participants aged 40 years or less, and in those previously infected with SARS CoV-2. The severity of most adverse reactions was mild to moderate. No serious case or death was reported.Conclusion: The adverse reactions reported by the participants were mild to moderate in severity, and for a short duration. The findings of this study help us to address the vaccine hesitancy caused by worries about severe adverse effects associated with the COVID-19 vaccine.Keywords: adverse effects, COVID-19, vaccine, ChAdOx1 nCoV-19, AstraZeneca
first_indexed 2024-12-14T09:25:54Z
format Article
id doaj.art-ead681b384db4e86991eb2a18d80f2a8
institution Directory Open Access Journal
issn 1178-6973
language English
last_indexed 2024-12-14T09:25:54Z
publishDate 2021-10-01
publisher Dove Medical Press
record_format Article
series Infection and Drug Resistance
spelling doaj.art-ead681b384db4e86991eb2a18d80f2a82022-12-21T23:08:11ZengDove Medical PressInfection and Drug Resistance1178-69732021-10-01Volume 144077408369401Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, AfghanistanAzimi MDehzad WMAtiq MABahain BAsady AMahmoodullah Azimi,1 Wazhma Masoom Dehzad,1 Mohammad Asif Atiq,1 Barin Bahain,1 Abdullah Asady2 1Department of Clinical Pharmacology, Kabul University of Medical Sciences, Kabul, Afghanistan; 2Department of Microbiology, Kabul University of Medical Sciences, Kabul, AfghanistanCorrespondence: Abdullah AsadyDepartment of Microbiology, Kabul University of Medical Sciences, Kabul, AfghanistanTel +93731087928Email asady_abdullah@yahoo.comPurpose: To evaluate the occurrence, extent, and severity of adverse reactions associated with the vaccine of COVID-19 (ChAdOx1 nCoV-19 vaccine or AstraZeneca) among Kabul University of Medical Sciences staff.Patients and Methods: A retrospective observational, interview-based study was conducted from 4 to 20 April, 2021, to evaluate the adverse reactions associated with the vaccine of COVID-19 (ChAdOx1 nCoV-19 vaccine or AstraZeneca) among the staff and lecturers of the Kabul University of Medical Sciences, Kabul, Afghanistan. Participants were interviewed following the administration of the first dose of the AstraZeneca vaccines. They were asked to report any adverse reactions that occurred within 8– 10 days after vaccination. The frequency, duration, severity, and outcome of the reactions were recorded. Association of the adverse reactions was analysed with the ages of participants and previous infection with SARS CoV-2.Results: The most common adverse reactions reported by the participants were muscle pain (68.3%), local pain (58.8%) at the site of injection (68.3%), fever (66.3%) and fatigue (66.3%). Almost half of the respondents reported chills, joint pain and headache after receiving the first shot of the vaccine. The frequency of adverse reactions was higher in participants aged 40 years or less, and in those previously infected with SARS CoV-2. The severity of most adverse reactions was mild to moderate. No serious case or death was reported.Conclusion: The adverse reactions reported by the participants were mild to moderate in severity, and for a short duration. The findings of this study help us to address the vaccine hesitancy caused by worries about severe adverse effects associated with the COVID-19 vaccine.Keywords: adverse effects, COVID-19, vaccine, ChAdOx1 nCoV-19, AstraZenecahttps://www.dovepress.com/adverse-effects-of-the-covid-19-vaccine-reported-by-lecturers-and-staf-peer-reviewed-fulltext-article-IDRadverse effectscovid-19vaccinechadox1 ncov-19astrazeneca
spellingShingle Azimi M
Dehzad WM
Atiq MA
Bahain B
Asady A
Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan
Infection and Drug Resistance
adverse effects
covid-19
vaccine
chadox1 ncov-19
astrazeneca
title Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan
title_full Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan
title_fullStr Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan
title_full_unstemmed Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan
title_short Adverse Effects of the COVID-19 Vaccine Reported by Lecturers and Staff of Kabul University of Medical Sciences, Kabul, Afghanistan
title_sort adverse effects of the covid 19 vaccine reported by lecturers and staff of kabul university of medical sciences kabul afghanistan
topic adverse effects
covid-19
vaccine
chadox1 ncov-19
astrazeneca
url https://www.dovepress.com/adverse-effects-of-the-covid-19-vaccine-reported-by-lecturers-and-staf-peer-reviewed-fulltext-article-IDR
work_keys_str_mv AT azimim adverseeffectsofthecovid19vaccinereportedbylecturersandstaffofkabuluniversityofmedicalscienceskabulafghanistan
AT dehzadwm adverseeffectsofthecovid19vaccinereportedbylecturersandstaffofkabuluniversityofmedicalscienceskabulafghanistan
AT atiqma adverseeffectsofthecovid19vaccinereportedbylecturersandstaffofkabuluniversityofmedicalscienceskabulafghanistan
AT bahainb adverseeffectsofthecovid19vaccinereportedbylecturersandstaffofkabuluniversityofmedicalscienceskabulafghanistan
AT asadya adverseeffectsofthecovid19vaccinereportedbylecturersandstaffofkabuluniversityofmedicalscienceskabulafghanistan